開設賬戶
模擬帳戶
關於我們
即時報價及新聞
市場分析
財經日曆
每日市場分析
交易平台
下載及介紹
使用教學
交易細則
各項細則
資金提存
推廣和資訊
常見問題
聯絡我們
繁
简
EN
客户登入
開設賬戶
模擬帳戶
繁
简
EN
客户登入
開設賬戶
模擬帳戶
關於我們
上志國際介紹
上志國際特點
即時報價及新聞
即時報價
即時新聞
市場分析
財經日曆
市場分析
交易平台
平台特點
平台教學
交易細則
各項細則
資金提存
推廣和資訊
常見問題
聯絡我們
關於我們
交易細則
貴金屬市場
交易平台
市場分析
推廣和資訊
常見問題
聯絡我們
繁
简
EN
韓國KOSPI指數站上6800點,日內漲5.24%。
2026-08-20
韓國KOSPI指數站上6800點,日內漲5.24%。
返回
其他消息
2026-08-20
Sources said on the 20th UEFA, the AFC and CONCACAF are discussing initiating a vote of no confidence in FIFA president Gianni Infantino to seek his removal. FIFA statutes allow the FIFA Council to convene an extraordinary congress at any time; if at least one-fifth of FIFA's 211 member associations submit a written request, the Council must call one. Infantino plans to stand for re-election and retains backing from some member associations, including CAF members.
Sources said on the 20th UEFA, the AFC and CONCACAF are discussing initiating a vote of no confidence in FIFA president Gianni Infantino to seek his removal. FIFA statutes allow the FIFA Council to convene an extraordinary congress at any time; if at least one-fifth of FIFA's 211 member associations submit a written request, the Council must call one. Infantino plans to stand for re-election and retains backing from some member associations, including CAF members.
2026-08-20
Shandong’s draft "15th Five-Year" pharmaceutical industry development action plan, published for consultation, aims to cultivate more than 10 provincial-level flagship industry-chain leader firms and build an ecosystem led by innovative drug champions with complementary niche strengths. The draft encourages these chain-leader firms to expand through mergers & acquisitions and strategic cooperation to achieve scale and integration, strengthening ecosystem leadership and core competitiveness. It d
Shandong’s draft "15th Five-Year" pharmaceutical industry development action plan, published for consultation, aims to cultivate more than 10 provincial-level flagship industry-chain leader firms and build an ecosystem led by innovative drug champions with complementary niche strengths. The draft encourages these chain-leader firms to expand through mergers & acquisitions and strategic cooperation to achieve scale and integration, strengthening ecosystem leadership and core competitiveness. It directs lead firms to leverage technology, capital, brand and market advantages to form innovation consortia, compile a catalogue of key common technologies, and coordinate upstream‑downstream joint R&D. Lead firms are also urged to open supply‑chain and innovation‑chain resources to integrate smaller suppliers, promoting a development pattern of lead-firm guidance, chain-wide coordination and cluster advancement to consolidate the sector’s scale advantage.
Chat with us
, powered by
LiveChat